TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Chinese herbs can facilitate sputum culture conversion, promote lesion absorption, and enhance clinical symptoms and quality of life for patients with Mycobacterium abscessus pulmonary disease (MAB-PD). The investigators aimed to evaluate the efficacy of Chinese herbs as adjunct therapy to improve cure rates or reduce recurrence rates during the continuation phase of MAB-PD treatment.
Epistemonikos ID: 42054ce3a3c6e65f5fc66e3d995575021556fbb6
First added on: Dec 23, 2025